Article info

Download PDFPDF

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19

Authors

  1. Correspondence to Mrs Shaghayegh Mohsenian Naghani, Pharmacy, Elisabeth-TweeSteden Ziekenhuis, Tilburg, Netherlands; s.mohseniannaghani{at}etz.nl
View Full Text

Citation

Mohsenian Naghani S, Jansen MM, Jaspers T, et al
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19

Publication history

  • Received November 11, 2020
  • Revised March 13, 2021
  • Accepted March 16, 2021
  • First published May 14, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.